Search

everythinglearnresearchcommunity

for

Search:↓

Most pregnant women experience skin changes like darkening and stretch marks, and some may have skin conditions that usually get better after giving birth.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Thyroid hormones are important for skin health and might help treat skin diseases, but more research is needed to understand their effects fully.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Use "female pattern hair loss" term, finasteride may help, more research needed.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Ketoconazole shampoo with finasteride improves hair density in men with hair loss.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

Finasteride safely reduces excessive hair growth in women.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Cronkhite-Canada Syndrome often leads to death within 6-18 months.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Certain Chinese herbs, especially Cacumen platycladi, can promote hair regrowth and reduce hair loss-related hormone levels in mice.

PRFM may help treat hair loss, especially in mild cases.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Thyroid hormones affect skin texture, hair and nail growth, and can cause skin diseases related to thyroid problems.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.